Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
AUTOR(ES)
Cusumano, V
RESUMO
We investigated the role of interleukin-10 (IL-10) in a neonatal mouse model of lethal group B streptococci (GBS) sepsis. Plasma IL-10 levels significantly increased at 24 and 48 h after GBS inoculation. Neutralization of IL-10 with specific antibodies had no effect on lethality. Administration of recombinant IL-10 at 20 or 4 h before challenge, but not at later times, resulted in decreased tumor necrosis factor alpha levels and improved survival. IL-10 could be potentially useful for the treatment of GBS sepsis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174154Documentos Relacionados
- Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis
- A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.
- Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock.
- Blocking the Receptor for Interleukin 10 Protects Mice from Lethal Listeriosis
- Protease-deficient herpes simplex virus protects mice from lethal herpesvirus infection.
